Growth and differentiation of pluripotent embryonal carcinoma cells in the Snell dwarf mouse. 1984

A W van der Kamp, and S C van Buul-Offers, and E J Roza-de Jongh, and M Feijlbrief, and J Branger, and E van Rongen

To investigate the influence of hormones on the process of cellular differentiation the growth and differentiation of a transplantable tumour, induced by inoculation of pluripotent mouse embryonal carcinoma (EC) cells have been studied in athymic nude mice and, normal and hypopituitary Snell dwarf mice. All athymic nude mice developed tumours independent of the numbers of cells inoculated. In contrast, the tumour percentage in normal Snell mice was lower, showing a dose-dependent increase of takes. In dwarfs tumour percentage was comparable with that observed in normal Snell mice. The morphological differentiation of teratocarcinomas grown in athymic nude mice, normal and dwarfed Snell mice shows derivatives of all three germ layers next to undifferentiated embryonal carcinoma cells. This suggests that the pituitary hormonal deficiencies of the dwarfs (growth hormone, thyroid stimulating hormone and prolactin) did not influence the tumour induction nor the development of the different tissues present in this type of tumour.

UI MeSH Term Description Entries
D008297 Male Males
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013234 Stem Cells Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells. Colony-Forming Units,Mother Cells,Progenitor Cells,Colony-Forming Unit,Cell, Mother,Cell, Progenitor,Cell, Stem,Cells, Mother,Cells, Progenitor,Cells, Stem,Colony Forming Unit,Colony Forming Units,Mother Cell,Progenitor Cell,Stem Cell
D013724 Teratoma A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642) Dysembryoma,Teratoid Tumor,Teratoma, Cystic,Teratoma, Mature,Teratoma, Benign,Teratoma, Immature,Teratoma, Malignant,Benign Teratoma,Benign Teratomas,Dysembryomas,Immature Teratoma,Immature Teratomas,Malignant Teratoma,Malignant Teratomas,Teratoid Tumors,Teratomas,Teratomas, Benign,Teratomas, Immature,Teratomas, Malignant,Tumor, Teratoid,Tumors, Teratoid

Related Publications

A W van der Kamp, and S C van Buul-Offers, and E J Roza-de Jongh, and M Feijlbrief, and J Branger, and E van Rongen
February 1987, Experimental cell research,
A W van der Kamp, and S C van Buul-Offers, and E J Roza-de Jongh, and M Feijlbrief, and J Branger, and E van Rongen
July 1987, Acta endocrinologica,
A W van der Kamp, and S C van Buul-Offers, and E J Roza-de Jongh, and M Feijlbrief, and J Branger, and E van Rongen
November 1992, BioEssays : news and reviews in molecular, cellular and developmental biology,
A W van der Kamp, and S C van Buul-Offers, and E J Roza-de Jongh, and M Feijlbrief, and J Branger, and E van Rongen
October 1983, British journal of experimental pathology,
A W van der Kamp, and S C van Buul-Offers, and E J Roza-de Jongh, and M Feijlbrief, and J Branger, and E van Rongen
January 1984, Neurochemical pathology,
A W van der Kamp, and S C van Buul-Offers, and E J Roza-de Jongh, and M Feijlbrief, and J Branger, and E van Rongen
January 2005, Physiological research,
A W van der Kamp, and S C van Buul-Offers, and E J Roza-de Jongh, and M Feijlbrief, and J Branger, and E van Rongen
April 1994, European journal of orthodontics,
A W van der Kamp, and S C van Buul-Offers, and E J Roza-de Jongh, and M Feijlbrief, and J Branger, and E van Rongen
March 1954, Bollettino della Societa italiana di biologia sperimentale,
A W van der Kamp, and S C van Buul-Offers, and E J Roza-de Jongh, and M Feijlbrief, and J Branger, and E van Rongen
August 1985, Developmental biology,
A W van der Kamp, and S C van Buul-Offers, and E J Roza-de Jongh, and M Feijlbrief, and J Branger, and E van Rongen
January 1989, Biochemical Society symposium,
Copied contents to your clipboard!